Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Synthesis, in vitro and in vivo characterization of (64)Cu(I) complexes derived from hydrophilic tris(hydroxymethyl)phosphane and 1,3,5-triaza-7-phosphaadamantane ligands.

Alidori S, Gioia Lobbia G, Papini G, Pellei M, Porchia M, Refosco F, Tisato F, Lewis JS, Santini C.

J Biol Inorg Chem. 2008 Feb;13(2):307-15. Epub 2007 Nov 27.

PMID:
18043951
2.

Synthesis and structural characterization of copper(I) complexes bearing N-methyl-1,3,5-triaza-7-phosphaadamantane (mPTA): cytotoxic activity evaluation of a series of water soluble Cu(I) derivatives containing PTA, PTAH and mPTA ligands.

Porchia M, Benetollo F, Refosco F, Tisato F, Marzano C, Gandin V.

J Inorg Biochem. 2009 Dec;103(12):1644-51. doi: 10.1016/j.jinorgbio.2009.09.005. Epub 2009 Sep 13.

PMID:
19822369
3.

Investigation into 64Cu-labeled Bis(selenosemicarbazone) and Bis(thiosemicarbazone) complexes as hypoxia imaging agents.

McQuade P, Martin KE, Castle TC, Went MJ, Blower PJ, Welch MJ, Lewis JS.

Nucl Med Biol. 2005 Feb;32(2):147-56.

PMID:
15721760
4.

64Cu-azabicyclo[3.2.2]nonane thiosemicarbazone complexes: radiopharmaceuticals for PET of topoisomerase II expression in tumors.

Wei L, Easmon J, Nagi RK, Muegge BD, Meyer LA, Lewis JS.

J Nucl Med. 2006 Dec;47(12):2034-41.

5.

An improved synthesis and biological evaluation of a new cage-like bifunctional chelator, 4-((8-amino-3,6,10,13,16,19-hexaazabicyclo[6.6.6]icosane-1-ylamino)methyl)benzoic acid, for 64Cu radiopharmaceuticals.

Cai H, Li Z, Huang CW, Park R, Shahinian AH, Conti PS.

Nucl Med Biol. 2010 Jan;37(1):57-65. doi: 10.1016/j.nucmedbio.2009.09.001. Epub 2009 Oct 12.

PMID:
20122669
6.

Optimization of a Pretargeted Strategy for the PET Imaging of Colorectal Carcinoma via the Modulation of Radioligand Pharmacokinetics.

Zeglis BM, Brand C, Abdel-Atti D, Carnazza KE, Cook BE, Carlin S, Reiner T, Lewis JS.

Mol Pharm. 2015 Oct 5;12(10):3575-87. doi: 10.1021/acs.molpharmaceut.5b00294. Epub 2015 Aug 31.

7.

Cu(I) complexes bearing the new sterically demanding and coordination flexible tris(3-phenyl-1-pyrazolyl)methanesulfonate ligand and the water-soluble phosphine 1,3,5-triaza-7-phosphaadamantane or related ligands.

Wanke R, Smoleński P, da Silva MF, Martins LM, Pombeiro AJ.

Inorg Chem. 2008 Nov 3;47(21):10158-68. doi: 10.1021/ic801254b. Epub 2008 Oct 8.

PMID:
18841929
8.

Synthesis, characterization, and in vitro antitumor properties of tris(hydroxymethyl)phosphine copper(I) complexes containing the new bis(1,2,4-triazol-1-yl)acetate ligand.

Marzano C, Pellei M, Colavito D, Alidori S, Lobbia GG, Gandin V, Tisato F, Santini C.

J Med Chem. 2006 Dec 14;49(25):7317-24.

PMID:
17149861
9.

198Au-labeled hydroxymethyl phosphines as models for potential therapeutic pharmaceuticals.

Berning DE, Katti KV, Volkert WA, Higginbotham CJ, Ketring AR.

Nucl Med Biol. 1998 Aug;25(6):577-83.

PMID:
9751426
10.

Evaluation of 64Cu labeled GX1: a phage display peptide probe for PET imaging of tumor vasculature.

Chen K, Sun X, Niu G, Ma Y, Yap LP, Hui X, Wu K, Fan D, Conti PS, Chen X.

Mol Imaging Biol. 2012 Feb;14(1):96-105. doi: 10.1007/s11307-011-0479-1.

11.

In vitro and in vivo evaluation of ⁶⁴Cu-radiolabeled KCCYSL peptides for targeting epidermal growth factor receptor-2 in breast carcinomas.

Kumar SR, Gallazzi FA, Ferdani R, Anderson CJ, Quinn TP, Deutscher SL.

Cancer Biother Radiopharm. 2010 Dec;25(6):693-703. doi: 10.1089/cbr.2010.0820.

12.

In vivo behavior of copper-64-labeled methanephosphonate tetraaza macrocyclic ligands.

Sun X, Wuest M, Kovacs Z, Sherry AD, Motekaitis R, Wang Z, Martell AE, Welch MJ, Anderson CJ.

J Biol Inorg Chem. 2003 Jan;8(1-2):217-25. Epub 2002 Oct 11.

PMID:
12459917
13.

Synthesis and pre-clinical evaluation of a new class of high-affinity 18F-labeled PSMA ligands for detection of prostate cancer by PET imaging.

Kelly J, Amor-Coarasa A, Nikolopoulou A, Kim D, Williams C Jr, Ponnala S, Babich JW.

Eur J Nucl Med Mol Imaging. 2017 Apr;44(4):647-661. doi: 10.1007/s00259-016-3556-5. Epub 2016 Nov 15.

14.

Syntheses, in vitro and in vivo characterization of a 99mTc-(I)-tricarbonyl-benzylamino-dihydroxymethyl phosphine (NP(2)) chelate.

Kothari KK, Raghuraman K, Pillarsetty NK, Hoffman TJ, Owen NK, Katti KV, Volkert WA.

Appl Radiat Isot. 2003 May;58(5):543-9.

PMID:
12735970
15.

PET imaging of oncogene overexpression using 64Cu-vasoactive intestinal peptide (VIP) analog: comparison with 99mTc-VIP analog.

Thakur ML, Aruva MR, Gariepy J, Acton P, Rattan S, Prasad S, Wickstrom E, Alavi A.

J Nucl Med. 2004 Aug;45(8):1381-9.

16.

Novel method to label solid lipid nanoparticles with 64cu for positron emission tomography imaging.

Andreozzi E, Seo JW, Ferrara K, Louie A.

Bioconjug Chem. 2011 Apr 20;22(4):808-18. doi: 10.1021/bc100478k. Epub 2011 Mar 9.

17.

In vitro antitumour activity of water soluble Cu(I), Ag(I) and Au(I) complexes supported by hydrophilic alkyl phosphine ligands.

Santini C, Pellei M, Papini G, Morresi B, Galassi R, Ricci S, Tisato F, Porchia M, Rigobello MP, Gandin V, Marzano C.

J Inorg Biochem. 2011 Feb;105(2):232-40. doi: 10.1016/j.jinorgbio.2010.10.016. Epub 2010 Nov 5.

PMID:
21194623
18.

Production and tumour uptake of [64Cu]Pyruvaldehyde-bis (N4-methylthiosemicarbazone) for PET and/or therapeutic purposes.

Jalilian AR, Rowshanfarzad P, Kamrani YY, Shafaii K, Mirzaii M.

Nucl Med Rev Cent East Eur. 2007;10(1):6-11.

PMID:
17694494
19.

Comparison of (64)Cu-complexing bifunctional chelators for radioimmunoconjugation: labeling efficiency, specific activity, and in vitro/in vivo stability.

Cooper MS, Ma MT, Sunassee K, Shaw KP, Williams JD, Paul RL, Donnelly PS, Blower PJ.

Bioconjug Chem. 2012 May 16;23(5):1029-39. doi: 10.1021/bc300037w. Epub 2012 Apr 13.

20.

In vitro antitumor activity of the water soluble copper(I) complexes bearing the tris(hydroxymethyl)phosphine ligand.

Marzano C, Gandin V, Pellei M, Colavito D, Papini G, Lobbia GG, Del Giudice E, Porchia M, Tisato F, Santini C.

J Med Chem. 2008 Feb 28;51(4):798-808. doi: 10.1021/jm701146c. Epub 2008 Feb 6.

PMID:
18251492

Supplemental Content

Support Center